Post Profile






Allergan completes restructuring, pushes hard in China

PARIS (Reuters) - Botox-maker Allergan has embarked on a big push in China where it plans to hire 200 additional staff this year and will also be on the lookout for potential acquisitions in the country, a senior executive told Reuters on Friday.
read more

share

Related Posts


Push by Allergan to Acquire Salix Loses Steam

Business & Finance : DealBook

Allergan, the maker of Botox, sought a $10 billion deal for Salix that would not have required shareholder approval, a move intended to derail a takeover effort by Valeant and Pershing Square.

Allergan Seeks Deal With Salix To Fend Off Valeant: WSJ

Business & Finance : Business Insider: Clusterstock

(Reuters) - Botox maker Allergan Inc has approached Salix Pharmaceuticals Ltd and at least one other company about a potential takeover in a bid to avert the $53 billion hostile takeover from Valeant Pharmaceuticals International In...

Allergan to buy Tobira in push for fatty liver disease drugs

Health : Reuters: Health

(Reuters) - Botox maker Allergan Plc, in its third acquisition this month, said it would pay up to $1.7 billion for Tobira Therapeutics Inc to get a leg up in the race to develop therapies for NASH, an incurable fatty liver disease ...

Exclusive: Actavis Plans New Merger Approach For Allergan - Sources

Business & Finance : Business Insider: Money Game

By Nadia Damouni and Soyoung Kim NEW YORK (Reuters) - Actavis Plc plans to approach Allergan Inc again about a potential merger, as the Botox maker warms up to the possibility of a sale, people familiar with the matter said on Tuesd...

Valeant Ready To Raise Allergan Bid To At Least $200/share

Business & Finance : Business Insider: Money Game

(Reuters) - Valeant Pharmaceuticals International Inc said it is prepared to improve its offer for Allergan Inc to at least $200 per share. The Botox maker's shares closed at $184.21 on Friday. Valeant Chief Executive Michael Pearso...

Comments


Copyright © 2016 Regator, LLC